Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centro de Diabetes Curitiba (CDC) is a specialized medical institution located in Curitiba, Brazil, dedicated to the treatment and clinical study of diabetes and endocrine disorders. Founded in 1990, the center operates as a multidisciplinary clinic providing expert care in endocrinology, nutrition, and patient education. CDC is widely recognized as a leading clinical research site in Latin America, having participated in more than 150 international clinical trials across Phases 2, 3, and 4. The center collaborates with major global pharmaceutical companies to evaluate novel therapies for diabetes, obesity, and metabolic syndrome. Integrated within the Hospital Nossa Senhora das Graças, CDC utilizes a robust infrastructure to maintain high standards of clinical practice and data integrity. Its contributions have been pivotal in the regulatory approval of several landmark metabolic treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centro de Diabetes Curitiba.